Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Dopamine D2 Receptor Blocking Peptide (AC1351)
Cat.#: ACPP-1351
Specifications
Despition Dopamine D2 Receptor Blocking Peptide for Immunodepletion, Immunocompetition SIZE 250 µg Applications Immunodepletion & Immunocompetition assay Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1678 Human SDCBP Protein (AC1678) 5 µg inquiry ACPP-1159 Recombinant Mouse SIRP alpha Protein (6×His Tag) (AC1159) 50 µg inquiry ACPP-1776 Human Acrp30 Protein, HMW (AC1776) 2 µg inquiry ACPP-1400 ACTH (AC1400) 2 mg inquiry ACPP-1367 Myocilin Blocking Peptide (AC1367) 250 µg inquiry ACPP-1220 ELOVL4 Blocking Peptide (AC1220) 250 µg inquiry ACPP-1648 Human RAMP1 Protein (AC1648) 2 µg inquiry ACPP-1779 Human HSD17B10 Protein (AC1779) 5 µg inquiry ACPP-1472 Human PAX8 Protein (AC1472) 2 µg inquiry ACPP-1767 Human YIF1B Protein (AC1767) 5 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket